HomeHOWL • NASDAQ
add
Werewolf Therapeutics Inc
Previous close
$6.24
Day range
$5.96 - $6.49
Year range
$1.57 - $8.19
Market cap
260.95M USD
Avg Volume
176.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.50M | -79.39% |
Operating expense | 7.68M | 3.73% |
Net income | -12.00M | -0.61% |
Net profit margin | -799.67 | -388.17% |
Earnings per share | -0.33 | 15.38% |
EBITDA | -12.50M | 2.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 134.34M | 3.89% |
Total assets | 174.83M | 9.10% |
Total liabilities | 63.46M | 67.40% |
Total equity | 111.37M | — |
Shares outstanding | 42.74M | — |
Price to book | 2.19 | — |
Return on assets | -18.45% | — |
Return on capital | -19.76% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -12.00M | -0.61% |
Cash from operations | -4.58M | 61.37% |
Cash from investing | -198.00K | 61.78% |
Cash from financing | 9.07M | 622.37% |
Net change in cash | 4.29M | 138.54% |
Free cash flow | -1.63M | 83.38% |
About
Founded
2017
Headquarters
Website
Employees
47